Transforming Clinical and Disease Biology Insights into Drug and Diagnostic Discoveries

A new paradigm in drug and diagnostic development is emerging. Exciting scientific discoveries in genome biology and technology are paving the way to new product development and commercial opportunities for Rx, Dx and technology platform companies. Join us in San Francisco this August for IBC's all new Drug & Diagnostic Development event - featuring these 4 compelling conferences:

Conference Topics for 2012:

The Future of Rx/Dx Summit		Antibody-Drug Conjugates, Bispecifics & Empowered Antibodies		Next-Gen Sequencing Applications & Translational Technologies		Clinical Biomarkers & New Frontiers in Cancer
Rx/Dx Development, Commercialization & Collaboration Models Future Clinical Diagnostics »More Information »Download Brochure »Register		Next-Generation Antibody-Drug Conjugates Empowered Antibodies & Bispecifics »More Information »Download Brochure »Register		Clinical & Research Applications of Next-Generation Sequencing Translational Biology & Technology »More Information »Download Brochure »Register		Clinically-Relevant Biomarkers New Frontiers in Cancer: Novel Clinical Paradigms »More Information »Download Brochure »Register

As an attendee, you can mix-and-match session from all 4 co-located summits

View the Event-at-a-Glance (PDF) for all 4 co-located Summits.

Gain Scientific and Strategic Insights from these Thought-Leading Speakers:

Joji Nakayama, Daiichi-Sankyo, Japan

Victor Velculescu, M.D., Ph.D., Ludwig Center at John Hopkins

Richard K. Wilson, Ph.D., Washington University

Elizabeth S. Mansfield, Ph.D., CDER, US FDA

Ron Andrews, Life Technologies

Michael Pellini, Foundation Medicine

Garry P. Nolan, Ph.D., Stanford School of Medicine

View the Entire Line-up of Keynote & Featured Speakers

Request Information

Sign up to receive email updates or new information on the 2012 event as it becomes available.

Networking

Continue to Connect and Communicate with your Peers All Year Round

Join "Drug Discovery & Development Professionals"

Join "Antibody & Protein Therapeutics - From Discovery to Production"

Follow @drugdisc on Twitter for special offers and news about the event.

Connect on Facebook

Add the event to your calendar by clicking "Attending" on the event page

RSS News Feed

See Who Attends

Read a sample of who attended the 2011 conference.

View Free Webinars

Next Generation Sequencing At Genomic Health: Turning the Promise of Genomics into the Practice of Medicine
Joffre Baker, Ph.D., Chief Scientific Officer, Genomic Health, Inc.

A New Vision for the Drug-Diagnostic Value Paradigm: Bringing Personalized Medicine to Market
Paul J. Beresford Ph.D., Vice President, Biodesix

Circulating Tumors Cells as Biomarkers: Opportunities for Noninvasive Tumor Characterization and Patient Stratification in Oncology
Yvon E. Cayre, M.D., Ph.D., Professor of Medicine, Pierre and Marie Curie University and Robert Debré University Hospital, France

Upcoming Live Webinar, Register Today

Tuesday, May 22, 2:00 pm EDT
Noninvasive Sequencing of Fetal DNA
Charles Cantor, Ph.D., Chief Scientific Officer, Sequenom, Inc.

»Register to attend these webinars live, or view them archived.